Alvotech (Alvotech) Current Accrued Expense : $55.99 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Alvotech Current Accrued Expense?

Alvotech's Current Accrued Expense for the quarter that ended in Dec. 2023 was $55.99 Mil.

Alvotech's quarterly Current Accrued Expense declined from Jun. 2023 ($28.86 Mil) to Sep. 2023 ($0.00 Mil) but then increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($55.99 Mil).

Alvotech's annual Current Accrued Expense increased from Dec. 2021 ($34.51 Mil) to Dec. 2022 ($36.59 Mil) and increased from Dec. 2022 ($36.59 Mil) to Dec. 2023 ($55.99 Mil).

Alvotech Current Accrued Expense Historical Data

The historical data trend for Alvotech's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Current Accrued Expense Chart

Alvotech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

16.42

34.51

36.59

55.99

Alvotech Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial								36.59	-	28.86	-	55.99

Alvotech Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Alvotech Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Alvotech's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Alvotech (Alvotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVO) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

ALVO:Iceland Z45:Germany

Address

9, rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.alvotech.com

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.